Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,022.95
(
0.80%
)
US TECH 100
25,535.20
(
1.56%
)
Dow Jones
48,463.72
(
-0.15%
)
Brent Oil
92.60
(
-0.07%
)
Bitcoin
75,045.48
(
0.29%
)
News Focus
News Focus
Post# of 257412
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

puravida

Send PM Follow Ignore
Followers 36
Posts 1737
Boards Moderated 0
Alias Born 05/13/2011

puravida

Re: None

Thursday, 06/27/2019 8:30:13 AM

Thursday, June 27, 2019 8:30:13 AM

Post# of 257412
DOVA PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR DOPTELET® (AVATROMBOPAG) FOR TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)

Company Strengthens Thrombocytopenia Portfolio with ITP Approval and Expanded Partnership with Salix for Chronic Liver Disease (CLD) Indication

Company to Host Conference Call at 9am EST



http://investors.dova.com/news-releases/news-release-details/dova-pharmaceuticals-announces-fda-approval-supplemental-new
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today